MEKINIST 0.5 MG TABLET

  • اسم المستحضر : MEKINIST 0.5 MG TABLET
  • اسم المصنع : Novartis Pharma AG, Switzerland
  • التصنيف : Import Product
  • الوكيل / الموزع : Masrouji Company Ltd
  • الشكل الصيدلاني : film coated tablet
  • المكونات الفعالة : Each tablet contains: Trametinib (as dimethyl sulfoxide) 0.5 mg
  • يستخدم لـ : Melanoma Trametinib as monotherapy or in combination with dabrafenib is indicated for the treatment of adult patients with unresectable or metastatic melanoma with a BRAF V600 mutation. Trametinib monotherapy has not demonstrated clinical activity in patients who have progressed on a prior BRAF inhibitor therapy. Adjuvant treatment of melanoma Trametinib in combination with dabrafenib is indicated for the adjuvant treatment of adult patients with Stage III melanoma with a BRAF V600 mutation, following complete resection. Non-small cell lung cancer (NSCLC) Trametinib in combination with dabrafenib is indicated for the treatment of adult patients with advanced non-small cell lung cancer with a BRAF V600 mutation.
  • رقم التسجيل : 61/6712/30
  • تاريخ التسجيل : 30-10-2018
  • تاريخ انتهاء التسجيل : 30-10-2023

Please Wait